O lung cancer it is neoplastic disease more deadly In Latin America and one that receives less attention from the health sector, the study "Lung Cancer in Latin America: It is time to stop looking elsewhere," carried out by The Economist Intelligence Unit (EIU).
In the study, presented under the congress of the Mexican Society of Oncology (SMEO), data from 12 Latin American countries was analyzed, indicating that in Mexico, 99% of the cases of lung cancer They are diagnosed in phase three or four, while in other countries of the region the rate is 85%.
Irene Mia, the global editorial director of the EIU, said that with respect to this type of cancer, there is no record nor
Sufficient data in the Latin American region, so we work on the identification of three priority areas in health policies for cancer control: tobacco control, access and early diagnosis.
The health specialists, who collaborated in the investigation, consider that the stigma about this type of cancer is a barrier that prevents the dedication of more specific policies and resources in relation to other types of cancer.
"It is believed that patients who smoked the disease," said Dr. Oscar Arrieta, head of the Pulmonary Unit of the National Cancer Institute (INCAN), and said that smoking is an addiction in which the Mexican state "did not do enough to avoid . "
Although smoking is still the main cause of
lung cancer, 40% is due to unrelated causes, such as the presence of arsenic in water, atmospheric pollution and the use of firewood as a fuel in kitchens.
In Mexico, this type of cancer is not covered by the Popular Insurance – that provides cover to more than 40% of the population that does not have private insurance or social security – that contributes to the positioning of the country at low levels of the country. Tobacco control, access and early diagnosis.
In Latin America, 60,000 people die every year from lung cancer, while in Mexico during 2010, 10,000 new cases were diagnosed and, according to Arrieta, by 2025 the number will be doubled to 20,000. that "the amount of mortality will be very similar."
Ricardo Pérez Cuevas, research director of the National Institute of Public Health, stated that the study reflects the challenges to improve the prevention, diagnosis and treatment of lung cancer and there is no single response to the problems linked to it in Latin America. Latina
Pérez Cuevas commented that in Mexico INCan, the Mexican Health Foundation and the National Institute of Public Health work on a proposal based on the costs of
fight against lung cancer And tobacco, which will be presented to the Mexican authorities.
"Our hope is that the policy for the treatment of lung cancer is stable, has the necessary background and we can advance the access and effectiveness of the treatment," concluded the specialist.